OT-82 is an Orally Active NAMPT Inhibitor with Antineoplastic Activity
Treatment of hematopoietic (HP) malignancies such as leukemia, lymphoma, and myeloma need improvement due to the drug high toxicity. Some effective anticancer agents are tissue-selective but not cancer-specific targets. These…